Format

Send to

Choose Destination
N Engl J Med. 2014 Aug 21;371(8):689-91. doi: 10.1056/NEJMp1314385.

FDA approval of bedaquiline--the benefit-risk balance for drug-resistant tuberculosis.

Author information

1
From the Office of Antimicrobial Products, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD.
PMID:
25140952
DOI:
10.1056/NEJMp1314385
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center